Form 4: Eastman Chemical Co Director David W. Raisbeck Reports Changes in Beneficial Ownership

Director David W. Raisbeck reports acquisition of phantom stock units through a director's deferred compensation plan.

Summary

• David W. Raisbeck, a director of Eastman Chemical Co, filed a Form 4 with the SEC detailing changes in his beneficial ownership.
• The report indicates the acquisition of 303 phantom stock units on April 5, 2024, under the Directors' Deferred Compensation Plan.
• These units represent deferred director's fees and are payable in cash after termination of service as a director.
• The reporting person directly owns 50,602 phantom stock units, which includes 951 units credited since October 6, 2023, as hypothetical reinvestment of dividend equivalents.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director is increasing their stake in the company, which can be seen as a positive sign. However, it's a routine transaction related to deferred compensation.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The Directors' Deferred Compensation Plan allows directors to defer fees into stock units, potentially increasing their stake in the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders, such as directors and officers, in the company's securities. This filing indicates a director's continued investment in the company through participation in a deferred compensation plan.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders.
• It signals that a director is increasing their investment in the company, which could be viewed positively by shareholders.

Key Dates